NRIX R&D Expenses
Nurix Therapeutics Inc · R&D Expenses
NRIX R&D Expenses
Latest reported$79.26Mperiod ending
NRIX Quarterly R&D Expenses ($10.43M → $79.26M)
Quarterly R&D Expenses
High-resolution chart · PNG
NRIX r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 79,260,000 | |
| 87,653,000 | |
| 84,137,000 | |
| 80,904,000 | |
| 86,120,000 | |
| 78,096,000 | |
| 69,663,000 | |
| 67,224,000 | |
| 55,481,000 | |
| 48,922,000 | |
| 50,005,000 | |
| 49,713,000 | |
| 47,856,000 | |
| 45,763,000 | |
| 45,816,000 | |
| 46,106,000 | |
| 47,761,000 | |
| 47,493,000 | |
| 43,137,000 | |
| 36,531,000 | |
| 30,906,000 | |
| 25,994,000 | |
| 23,003,000 | |
| 20,445,000 | |
| 18,939,000 | |
| 14,142,000 | |
| 12,967,000 | |
| 12,824,000 | |
| 11,008,000 | |
| 10,759,000 | |
| 10,434,000 |